COX-2-specific inhibition: Implications for clinical practice

Artikel in diesem Heft

1. New England Journal of Medicine article may be misleading about OMT
2. What is the standard of care for patients with low back pain?
3. Obesity article ignores surgery as possible option
4. Response: Obesity article ignores surgery as possible option
5. What's in a name?
6. The importance of referencing osteopathic medical literature
7. The dichotomy of overdosing or underdosing for pain
8. From the NICHHD: Day care has impact on mother-child bond
9. From the FDA: FDA allows soy health claim on food labels
10. From the CDC: Obesity increases dramatically in the United States
11. From the FDA: Abbott aggrees to correct manufacturing deficiencies
12. From the FDA: Abbott aggrees to correct manufacturing deficiencies
13. From the CDC: Flu, pneumonia shots urged
14. From the CDC: Rotavirus vaccine withdrawn from market
15. From the FDA: FDA approves Tamiflu for influenza
16. From the CDC: Guidelines modified for meningitis vaccination
17. Editorial comments
18. Risk factors for maternal colonization with group B beta-hemolytic streptococci
19. Multiple sclerosis--Part I. Overview pathophysiology, diagnostic evaluation, and clinical parameters
20. Use of ketorolac in renal colic
21. CME QUIZ
22. Medi-notes: OMT versus standard care for patients with low back pain
23. Heliobacter pylori in gastric carcinoma
24. Editor's message
25. The multisystem adverse effects of NSAID therapy
26. COX-1 and COX-2 in health and disease
27. Celecoxib for the treatment of pain and inflammation: the preclinical and clinical results
28. COX-2-specific inhibition: Implications for clinical practice